Reducing cardiovascular risk in high-risk patients with diabetes/metabolic syndrome

被引：0
|
作者：
Weissman, Peter [1 ,2 ]
Davidson, Michael [3 ]
机构：
[1] Univ Miami, Sch Med, Internal Med Endocrinol, Coral Gables, FL 33124 USA
[2] Osteoporosis Ctr, Miami, FL USA
[3] Univ Chicago, Pritzker Sch Med, Prevent Cardiol, Chicago, IL 60637 USA
来源：
POST ACCORD PERSPECTIVES: THE ROLE OF FENOFIBRATES: TRANSLATING THE EVIDENCE-BASED MEDICINE AND SCIENCE INTO CLINICAL PRACTICE FOR THE PRIMARY CARE PROVIDER | 2010年 / 274卷
关键词：
EXTREMITY ARTERIAL-DISEASE; TERM FENOFIBRATE THERAPY; TYPE-2; DIABETES-MELLITUS; ATHEROSCLEROSIS INTERVENTION; METABOLIC-SYNDROME; DOUBLE-BLIND; 9795; PEOPLE; MEN; BEZAFIBRATE; PREVENTION;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：26 / 42
页数：17
相关论文
共 50 条
  • [31] REDUCING THE INCIDENCE OF FALLS IN HIGH-RISK PATIENTS
    HILL, BA
    JOHNSON, R
    GARRETT, BJ
    JOURNAL OF NURSING ADMINISTRATION, 1988, 18 (7-8): : 24 - 28
  • [32] Impact of Metabolic Syndrome Components in High-Risk Cardiovascular Disease Development in Older Adults
    de Sousa Barbalho, Yuri Gustavo
    Stival, Marina Morato
    de Lima, Luciano Ramos
    Rodrigues da Silva, Izabel Cristina
    Silva, Alessandro de Oliveira
    Gomes da Costa, Manoela Vieira
    Santa Barbara Rehem, Tania Cristina Morais
    Funghetto, Silvana Schwerz
    CLINICAL INTERVENTIONS IN AGING, 2020, 15 : 1691 - 1700
  • [33] Prevalence and cardiovascular risk of the metabolic syndrome associated to undiagnosed impaired glucose metabolisin on high-risk Spanish population
    Martin, F
    Costa, B
    Cabre, J
    Piñol, J
    Basora, J
    DIABETES, 2003, 52 : A502 - A502
  • [34] Minority Angina Pectoris patients at high risk for diabetes and metabolic syndrome
    Kempf, Judith
    Van Norman, Sam
    Martinson, Melissa
    DIABETES, 2008, 57 : A279 - A279
  • [35] Prevalence and cardiovascular profile of metabolic syndrome in obese high-risk patients. An analysis from the SCOUT Trial
    Filardi, P. Perrone
    Urso, R.
    Chiariello, M.
    Maggioni, A. P.
    EUROPEAN HEART JOURNAL, 2009, 30 : 656 - 656
  • [36] Metabolic syndrome is an independent predictor of cardiovascular events in high-risk patients with occlusive and aneurysmatic peripheral arterial disease
    van Kuijk, Jan-Peter
    Flu, Willem-Jan
    Chonchol, Michel
    Bax, Jeroen J.
    Verhagen, Hence J. M.
    Poldermans, Don
    ATHEROSCLEROSIS, 2010, 210 (02) : 596 - 601
  • [37] Reducing the cardiovascular risk at patients with type 2 diabetes by controlling the risk factors
    Tudor, C.
    Jeberean, R. A.
    Buzas, R.
    Popescu, A.
    Ionita, M.
    ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 346 - 346
  • [38] Focus on type 2 diabetes, metabolic syndrome and cardiovascular risk
    POST ACCORD PERSPECTIVES: THE ROLE OF FENOFIBRATES: TRANSLATING THE EVIDENCE-BASED MEDICINE AND SCIENCE INTO CLINICAL PRACTICE FOR THE PRIMARY CARE PROVIDER, 2010, 274 : 20 - 25
  • [39] Metabolic syndrome risk for cardiovascular disease and diabetes in the ARIC study
    C M Ballantyne
    R C Hoogeveen
    A M McNeill
    G Heiss
    M I Schmidt
    B B Duncan
    J S Pankow
    International Journal of Obesity, 2008, 32 : S21 - S24
  • [40] Metabolic syndrome risk for cardiovascular disease and diabetes in the ARIC study
    Ballantyne, C. M.
    Hoogeveen, R. C.
    McNeill, A. M.
    Heiss, G.
    Schmidt, M. I.
    Duncan, B. B.
    Pankow, J. S.
    INTERNATIONAL JOURNAL OF OBESITY, 2008, 32 (Suppl 2) : S21 - S24
12345